
Shares of Revolution Medicines RVMD.O down 9.8% at $92.60 premarket after AbbVie ABBV.N denies takeover talks
ABBV says “not in discussions with Revolution Medicines” after WSJ report of advanced deal talks; RVMD declines to comment on speculation
RVMD stock had closed at an all-time high after WSJ's report and logged its biggest daily gain of 30% on record
WSJ had reported a potential valuation of $20 bln+ including premium
RVMD market value before the WSJ report was about $15.4 bln
RVMD gained over 82% in 2025